Abstract:Objective: Gasdermin D (GSDMD) is the key executioner of an inflammatory cell death mechanism known as pyroptosis. Recent reports have also implicated GSDMD in other mechanisms of cell death, including apoptosis, necroptosis, and NETosis. Given the role of dysregulated cell death in autoimmune syndromes such as systemic lupus erythematosus (SLE), this study was undertaken in a murine lupus model to investigate whether GSDMD plays a pathogenic role in systemic autoimmunity by promoting inflammatory cell death, leading to increased generation of nuclear autoantigens and autoantibodies. Methods: An imiquimod-induced model of SLE was tested in GSDMD-/- mice (n = 30), with wild-type (WT) mice as controls (n = 34), on a C57BL/6 background. At the time of euthanasia, the mice were examined for serum autoantibodies, immune complex deposition, organ inflammation, immune dysregulation, and type I interferon responses. A model of pristane-induced lung injury in GSDMD-/- mice (n = 7), with WT mice as controls (n = 10), was used to confirm the pulmonary phenotype. Regulation of various mechanisms of cell death by GSDMD was investigated in the mice. Results: Unexpectedly, GSDMD-/- mice developed enhanced mortality, more severe renal and pulmonary inflammation, and exacerbated autoantibody production in response to imiquimod. Pulmonary involvement was also more severe in the absence of GSDMD in mice with pristane-induced lung injury. Compared to WT mice, lack of GSDMD was associated with increased levels of circulating nuclear autoantigens (P < 0.01), anti-double-stranded DNA autoantibodies (P < 0.01), tissue immune complex deposition (P < 0.05), expansion of myeloid cell subsets (P < 0.05), and enhanced B cell activation and plasma cell differentiation (P = 0.001). Moreover, in the absence of GSDMD, enhanced autoantigen generation was associated with increased local induction of cell death in vivo. Conclusion: GSDMD negatively regulates autoantigen generation and immune dysregulation in response to tissue injury and may play previously unappreciated protective roles in systemic autoimmunity.

Gasdermin D is the only Gasdermin that provides protection against acute Salmonella gut infection in mice

Research Progress in Gasdermin Family Proteins and Their Association with Diseases

GSDMD protects intestinal epithelial cells against bacterial infections through its N-terminal activity impacting intestinal immune homeostasis

Gasdermins in Innate Host Defense Against Entamoeba histolytica and Other Protozoan Parasites

Intestinal epithelial Gasdermin C is induced by IL-4R/STAT6 signaling but is dispensable for gut immune homeostasis

Epithelial Gasdermin D shapes the host-microbial interface by driving mucus layer formation

Gasdermin D Licenses MHCII Induction to Maintain Food Tolerance in Small Intestine.

To die or not to die: Gasdermins in intestinal health and disease

Intestinal Gasdermins for regulation of inflammation and tumorigenesis

GSDMD Contributes to Host Defence Against Staphylococcus Aureus Skin Infection by Suppressing the Cxcl1–Cxcr2 Axis

Epithelial-derived gasdermin D mediates nonlytic IL-1β release during experimental colitis

Compound Loss of GSDMD and GSDME Function is Necessary to Achieve Maximal Therapeutic Effect in Colitis

Structures of Gasdermin-D C-Terminal Domain Reveal Mechanisms of Autoinhibition

Host Gasdermin D restrains systemic endotoxemia by capturing Proteobacteria in the colon of high-fat diet-feeding mice

The gasdermin family: emerging therapeutic targets in diseases

Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling

Up-regulation of Gasdermin C in Mouse Small Intestine is Associated with Lytic Cell Death in Enterocytes in Worm-Induced Type 2 Immunity.

Gasdermin D protects against noninfectious liver injury by regulating apoptosis and necroptosis

Effects of Gasdermin D in Modulating Murine Lupus and its Associated Organ Damage

Gasdermin E Suppresses Tumour Growth by Activating Anti-Tumour Immunity

P059 GSDMB triggers intestinal inflammation via regulating BHLHA15-mediated hyperactive unfolded protein response